Skip to main content
Clinical Trials/NCT03366506
NCT03366506
Recruiting
Not Applicable

Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)

Hadassah Medical Organization1 site in 1 country2,000 target enrollmentMarch 9, 2009
ConditionsALS

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ALS
Sponsor
Hadassah Medical Organization
Enrollment
2000
Locations
1
Primary Endpoint
Progression rate
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:-

  1. Differences between ethnic subgroups
  2. Differences between immigrant and native-born populations
  3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.

Detailed Description

Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:- 1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors. The clinical features will include pattern of onset, details of full clinical exam ( including ALSFRS-R score, power, reflexes, and other signs of upper or lower-motor neuron dysfunction. Correlations between different clinical parameters themselves will be made, as well as correlation between clinical parameters and other epidemiological factors.

Registry
clinicaltrials.gov
Start Date
March 9, 2009
End Date
January 2050
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Suspected, possible, probable ,definite ALS

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Progression rate

Time Frame: up to 10 years

Progression of ALSFRS-R score over time

Secondary Outcomes

  • Appearance of clinical features of UMN or LMN dysfunction(10 years)

Study Sites (1)

Loading locations...

Similar Trials